Wasatch Advisors LP Buys 303,277 Shares of Viemed Healthcare, Inc. (NASDAQ:VMD)

Wasatch Advisors LP grew its stake in Viemed Healthcare, Inc. (NASDAQ:VMD) by 19.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,848,884 shares of the company’s stock after acquiring an additional 303,277 shares during the period. Wasatch Advisors LP’s holdings in Viemed Healthcare were worth $13,552,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Evernest Financial Advisors LLC bought a new position in Viemed Healthcare in the 2nd quarter worth about $66,000. Perkins Coie Trust Co bought a new position in Viemed Healthcare in the 3rd quarter worth about $73,000. PDT Partners LLC bought a new position in Viemed Healthcare in the 3rd quarter worth about $78,000. Victory Capital Management Inc. grew its stake in Viemed Healthcare by 21.1% in the 2nd quarter. Victory Capital Management Inc. now owns 12,791 shares of the company’s stock worth $84,000 after acquiring an additional 2,226 shares in the last quarter. Finally, Walleye Capital LLC bought a new position in Viemed Healthcare in the 3rd quarter worth about $87,000. 74.24% of the stock is currently owned by institutional investors.

Insider Activity

In other news, Director Randy E. Dobbs sold 36,261 shares of the stock in a transaction that occurred on Wednesday, November 13th. The shares were sold at an average price of $9.28, for a total transaction of $336,502.08. Following the transaction, the director now directly owns 107,706 shares in the company, valued at approximately $999,511.68. This trade represents a 25.19 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Nitin Kaushal sold 30,000 shares of the firm’s stock in a transaction that occurred on Monday, November 11th. The shares were sold at an average price of $9.56, for a total transaction of $286,800.00. Following the completion of the sale, the director now owns 126,843 shares of the company’s stock, valued at approximately $1,212,619.08. This trade represents a 19.13 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 72,256 shares of company stock worth $674,739. Corporate insiders own 20.00% of the company’s stock.

Viemed Healthcare Price Performance

Shares of VMD stock opened at $8.67 on Friday. The company has a debt-to-equity ratio of 0.03, a current ratio of 1.31 and a quick ratio of 1.19. The company has a market capitalization of $337.61 million, a P/E ratio of 32.11 and a beta of 1.43. The company’s 50-day simple moving average is $8.61 and its two-hundred day simple moving average is $7.61. Viemed Healthcare, Inc. has a one year low of $6.21 and a one year high of $10.44.

Viemed Healthcare (NASDAQ:VMD) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.08 by $0.02. Viemed Healthcare had a net margin of 4.87% and a return on equity of 8.72%. The firm had revenue of $58.00 million for the quarter.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.